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Edited by Sandro SonninoAbstract 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocho-
line (OMPC, edelfosine) and 1-hexadecylphosphocholine
(HePC, miltefosine) represent two groups of synthetic ether lipid
analogues with anti-tumor activity. Because of their hydrophobic
nature, they may become incorporated into plasma membranes
of cells, and it has been argued that they may act via association
with lipid rafts. With the quenching of steady-state ﬂuorescence
of probes preferentially partitioning into sterol-rich ordered
domains (cholestatrienol and trans-parinaric acid), we showed
that OMPC and HePC by themselves did not form sterol-rich
domains in ﬂuid model membranes, in contrast to the two chain
ether lipid 1,2-O-dihexadecyl-sn-glycero-3-phosphocholine. Nev-
ertheless, all three ether lipids signiﬁcantly stabilized palmitoyl–
sphingomyelin/cholesterol-rich domains against temperature
induced melting. In conclusion, this study shows that anti-tumor
ether lipids are likely to aﬀect the properties of cholesterol–
sphingomyelin domains (i.e., lipid rafts) when incorporated into
cell membranes.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Synthetic ether analogues of phosphatidylcholine and lyso-
phosphatidylcholine constitute a new class of anti-tumor agents
which, in contrast to most of the currently used chemothera-
peutic drugs, do not target DNA but act at the cell membrane.
Antineoplastic ether-lipids comprise two classes – alkyllyso-
phospholipid derivates with the prototypical 1-O-octadecyl-2-
O-methyl-sn-glycero-3-phosphocholine (OMPC, Et-18-OCH3,
edelfosine), and alkylphosphocholines with the prototypical
hexadecylphosphocholine (HePC, miltefosine). In addition to
its antineoplastic eﬀect, miltefosine is useful for the treatmentAbbreviations: 7SLPC, 1-palmitoyl-2-stearoyl-(7-doxyl)-sn-glycero-3-
phosphocholine; CTL, cholesta-5,7,9(11)-trien-3-beta-ol; DHPC,
1,2-O-dihexadecyl-sn-glycero-3-phosphocholine; DPPC, 1,2-dipalmi-
toyl-sn-glycero-3-phosphocholine; HePC, 1-hexadecylphosphocholine;
DSC, diﬀerential scanning calorimetry; OMPC, 1-O-octadecyl-2-O-
methyl-sn-glycero-3-phosphocholine; PSM, D-erythro-N-palmitoyl–
sphingomyelin; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocho-
line; tPar, trans-parinaric acid; tPar-SM, D-erythro-N-trans-parinoyl–
sphingomyelin
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doi:10.1016/j.febslet.2006.03.079of human visceral leishmaniasis [1,2] and is also toxic in vitro
to other protozoan parasites [3–5].
The mechanism of cytotoxic and cytostatic action of ether
lipids is so far poorly understood [6]. The presence of ether
links protects these lipids from fast turn-over by phospholipa-
ses and they tend to accumulate in the cell membranes [7,8].
Both alkyllysophospholipids and alkylphosphocholines have
been shown to inhibit de novo phosphatidylcholine (PC) syn-
thesis at the rate-limiting CTP:phosphocholine cytidylyltrans-
ferase step [9–11], possibly by inducing a translocation of the
active membrane-bound form of the enzyme to the cytosol
[12]. Synthesis of PC is metabolically coupled to sphingomye-
lin (SM) synthesis, and indeed treatment of cells with HePC
decreased the transfer of PC-derived phosphorylcholine moi-
ety thereby increasing the mass of SM precursor ceramide
[13]. Except for their impact on lipid metabolism, anti-tumor
ether lipids also aﬀect a variety of cell surface receptors and
signal transduction pathways including EGF receptors, GM-
CSF receptors, Fas, PI-PLC, PtdIns 3-kinase, PKC, the
MAPK pathway, and the SAPK/JNK pathway [14–19].
Lipid rafts are considered to be dynamic plasma membrane
domains enriched in saturated sphingolipids and cholesterol
together with speciﬁc proteins. Recent studies with cultured
cells suggested that alkyllysophospholipids are internalized
by lipid raft-dependent endocytosis [20,21]. Anti-tumor lipids
could also act on cellular signaling by aﬀecting the protein
composition of rafts. Treatment of human leukemic cells with
edelfosine resulted in translocation of Fas into membrane rafts
and this apparently trigged apoptosis [16]. In yeast cells edelfo-
sine caused a redistribution of sterol from the plasma mem-
brane into the cell and also a mislocalization of essential
proton pump ATPase Pma1p out of rafts [22].
In this study, we employed domain selective ﬂuorescent
probes to look on the behavior of alkyllysophosphocholine
edelfosine (OMPC) and alkylphosphocholine miltefosine
(HePC) in model membrane systems containing unsaturated
phosphatidylcholine, saturated sphingomyelin and cholesterol.
Wewere particularly interested in the eﬀect ofOMPCandHePC
on the stability of sphingomyelin/cholesterol-rich domains in bi-
layer membranes. For comparison we included in our study also
1,2-O-dihexadecyl-sn-glycero-3-phosphocholine (DHPC), a
double chain ether-lipid with no reported anti-tumor activity.2. Materials and methods
2.1. Material
D-Erythro-N-palmitoyl–sphingomyelin (PSM) was puriﬁed from egg
yolk sphingomyelin (Avanti Polar Lipids, Alabaster, AL, USA) as de-
scribed in [23]. 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) andblished by Elsevier B.V. All rights reserved.
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were obtained from A.G. Scientiﬁc (San Diego, CA, USA). Choles-
terol was from Sigma Chemicals (St. Louis, MO, USA). (7-Doxyl)-
stearic acid was obtained from TCI (TCI Europe N.V., Belgium)
and was used for the synthesis of 1-palmitoyl-2-stearoyl-(7-doxyl)-sn-
glycero-3-phosphocholine (7SLPC) [24]. All organic solvents were ob-
tained from Merck (Darmstadt, Germany). Stock solutions of lipids
were prepared in hexane/2-propanol (3/2, v/v), stored in the dark at
20 C, and warmed to ambient temperature before use. Millipore
UF Plus produced water (resistivity 18.2 MX cm) was used.
trans-Parinaric acid (tPar) was obtained from Molecular Probes
(Eugene, OR, USA). D-Erythro-N-trans-parinoyl–sphingomyelin
(tParSM) was synthesized from trans-parinaric acid and D-erythro-
sphingosylphosphorylcholine (Matreya LLC, Pleasant Gap, PA,
USA) according to [25]. Cholesta-5,7,9(11)-trien-3-beta-ol (cholestat-
rienol, CTL) was synthesized and puriﬁed using the method published
in [26]. Probes were stored dry under argon in the dark at 87 C until
solubilized in argon-purged ethanol (CTL) or methanol (tPar,
tParSM). Solvents were saturated with argon before use to minimize
the risk of oxidation. Stock solutions of ﬂuorescent lipids were stored
in the dark at 20 C and used within a week.
2.2. Quenching of steady-state ﬂuorescence
In ﬂuorescence quenching studies, F samples consisted of
POPC:7SLPC:variable lipid:cholesterol (30:30:30:10 molar ratio) or
POPC:7SLPC:PSM:variable lipid:cholesterol (30:30:15:15:10) or
POPC:7SLPC:PSM:cholesterol (45:30:15:10). In F0 samples 7SLPC
was replaced by POPC. The variable lipids used were PSM, DPPC,
DHPC, OMPC and HePC. The samples were studied with CTL, tPar
or tParSM as the ﬂuorescent probe, which replaced 1 mol% of choles-
terol, POPC or PSM, respectively. CTL is ﬂuorescent cholesterol ana-
log which mimics well cholesterol behavior [27] and in lipid mixtures
containing coexisting liquid ordered (Lo) and disordered phases prefer-
entially associates with cholesterol-rich Lo domains [23]. Due to its
molecular shape, ﬂuorescent tPar also partitions preferentially into or-
dered phases where its quantum yield is higher then in less tightly
packed phases [28,29]. tParSM, as a ﬂuorescent analog of sphingomy-
elin, was used to probe sphingomyelin-rich domains.
The ﬂuorescence quenching method is described in more detail in
[23]. Brieﬂy, in lipid vesicles in which ordered and disordered domains
coexist, POPC together with the nitroxide-label quencher 7SLPC form
the disordered phase [31]. Fluorescent probes residing in sphingomye-
lin/cholesterol-rich ordered domains are shielded from quenching by
7SLPC. The melting of ordered domains is seen as a decrease of ﬂuores-
cence intensity of probe when that comes to closer contact with quench-
er due to more homogenous bilayer. In our measurements, the
ﬂuorescence intensity in the F samples is compared to the ﬂuorescence
intensity in F0 samples giving the fraction of quenched ﬂuorescence.
Vesicles used in steady-state ﬂuorescence measurements were pre-
pared to yield a ﬁnal lipid concentration of 50 lM. Sample preparation
and ﬂuorescence measurement details have been given recently and
were used here exactly as described [30]. Excitation of tPar was carried
out at 305 nm and the emission was recorded at 410 nm.
2.3. Diﬀerential scanning calorimetry
Miscibility of lipids with PSM was determined by diﬀerential scan-
ning calorimetry (DSC) using Nano II high-sensitivity scanning calo-
rimeter (Calorimeter Science Corporation, Provo, UT, USA).
Samples containing pure PSM, or mixture of lipid and PSM
(50:50 mol%) were dried under nitrogen and excess solvent was re-
moved by vacuum drying at room temperature for at least 2 h. The
dry lipids were resuspended in water, heated above the phase transition
temperature of particular lipids, shortly vortexed and sonicated for
4 min at 60 C in a Bransonic 2510 bath sonicator (Branson Ultrason-
ics Corporation, CT, USA). The ﬁnal concentration of lipids in the
solution was 1 mM. Two consecutive heating and cooling scans from
0 to 100 C at a scan rate of 0.5 C/min were performed.3. Results
3.1. Formation of ordered domains by ether lipids
In ternary systems containing cholesterol together with low
and high temperature melting lipid, cholesterol promotesphase separation into liquid disordered (Ld) cholesterol-poor
and liquid ordered (Lo) cholesterol-rich domains [31–33]. In
this study as a control system we have used bilayer membranes
consisting of POPC as a low Tm lipid, PSM as a high Tm lipid
and cholesterol in the ratio POPC:PSM:cholesterol 60:30:10 or
75:15:10 mol%. According to the phase diagram published by
de Almeida and coworkers [32], at 23 C both these mixtures
are composed only of a Ld phase enriched in POPC and a
Lo phase enriched in PSM and cholesterol.
The formation of sterol-rich ordered domains by anti-tumor
ether lipids and by PSM was studied by quenching of ﬂuores-
cence intensity of CTL (Fig. 1A). In agreement with published
results [23,34], the melting of PSM/sterol-rich domains in
bilayers containing 30 mol% PSM was clearly detected over a
temperature interval of 15–40 C. Importantly, by comparing
melting temperature of ordered domains as reported by do-
main selective probes and by scanning calorimetry for corre-
sponding bilayer compositions, Alanko and coworkers [34]
conﬁrmed that the presence of probe and quencher does not
disturb the temperature behavior of domains signiﬁcantly.
As apparent from Fig. 1A there are signiﬁcant diﬀerences in
formation of sterol-rich domains in bilayers containing ether
lipids. No melting of sterol-rich domains demonstrated as de-
crease of F/F0 ratio could be observed in bilayers containing
OMPC (30 mol%) or HePC (30 mol%). DHPC at 30 mol%
on the other hand was able to form sterol-rich domains which
had an intermediate melting stability compared to DPPC/ste-
rol and PSM/sterol-rich domains. The formation of choles-
terol-rich condensed domains in cholesterol-DHPC mixed
monolayers has previously been demonstrated by ﬂuorescence
microscopy [35].
To look at the possible formation of ordered domains other
than sterol-rich ones, we probed the same systems with tPar
(Fig. 1B). In bilayers containing 30 mol% HePC and OMPC
we observed no ordered domains into which tPar could parti-
tion. DPPC, DHPC or PSM at 30 mol% formed ordered do-
mains into which tPar could partition, and the melting of
these domains as reported by tPar was similar to the melting
reported by CTL.3.2. Eﬀect of ether lipids on sphingomyelin/sterol-rich domains
To study the inﬂuence of ether lipids on sphingomyelin/ste-
rol-rich domains we included OMPC, HePC, or DHPC in the
bilayer membranes together with PSM and cholesterol and
looked at the quenching susceptibility of CTL (Fig. 2A). The
temperature stability of PSM/sterol-rich domains was clearly
dependent on the amount of sphingomyelin with diﬀerent
melting temperatures when 15 or 30 mol% of PSM was present
in bilayers. The temperature interval of melting of PSM
(15 mol%)/sterol-rich domains is in good agreement with pre-
vious studies [30,34,36]. Including 15 mol% of ether lipid to
the bilayer membranes together with 15 mol% of PSM and
10 mol% cholesterol clearly stabilized the sterol-rich domains
against temperature induced melting. Still, the ether lipid in-
duced stability of PSM/sterol-rich domains had not reached
the stability of PSM (30 mol%)/sterol-rich domains. The incor-
poration of ether lipids into bilayers containing ordered do-
mains also enlarged the amplitude of F/F0 ratio decrease
suggesting increased partitioning of sterol (CTL) into PSM/
sterol-rich domains in presence of ether lipids. When the or-
dered domains were probed with tPar (Fig. 2B) and tPaSM
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as examined by ﬂuorescence quenching of CTL (panel A) and tPar
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main melting were very similar with all probes and for all com-
positions tested, conﬁrming the increased stability of
sphingomyelin/sterol-rich ordered domains in presence of ether
lipids.
3.3. The miscibility of sphingomyelin and ether lipids
Since ether lipids aﬀected PSM/sterol-rich domain stability
we were interested to determine their miscibility with PSM.
The DSC thermograms of equimolar mixtures of ether lipids
with PSM are shown in Fig. 3. The main gel-to-liquid crystal-
line transition of PSM has been previously reported to be at
41 C [37]. We determined the gel-to-liquid crystalline transi-
tion of DHPC to be at 44 C (not shown) in good agreement
with a study done by Bittman and coworkers [38]. The capabil-
ity of anti-tumor ether lipids to form bilayer structures implies
that they are able to insert themselves into lipid bilayer mem-
branes. Xie and coworkers [39] showed that OMPC inserts
into DPPC bilayers and aligns itself with the long acyl chain
being parallel to DPPC chains. The presence of 50 mol% of
DHPC in PSM bilayer decreased the main transition tempera-
ture of PSM by 2.1 C (Fig. 3). The miscibility of DHPC and
PSM was fairly good as demonstrated by single sharp peak
with high cooperativity both in heating and cooling scan.OMPC also decreased the PSM transition temperature (by
3.3 C) similarly as previously observed in bilayer mixtures
of OMPC with DPPC, DMPC or egg SM [39], but a broad
shoulder appeared on the high-temperature side of peak indi-
cating phase separation at least during the cooling (Fig. 3).
HePC showed rather poor miscibility with PSM with two
clearly separated peaks on the cooling scan.4. Discussion
Since the presence of saturated acyl chains in phospholipids
is consider being one of the requirements for the formation of
sterol-rich ordered domains [40–42], we tested whether satu-
rated ether lipids are able to form or participate in the forma-
tion of such domains. The interaction between HePC and
cholesterol has previously been studied in monolayers. Based
on collapse pressure values and analysis of mean molecular
areas of mixed HePC/cholesterol monolayers Go´mez-Serranil-
los and coworkers [43] concluded that mixed monolayers are
more stable as compared to pure components because of the
existence of the attractive interactions between HePC and cho-
lesterol. Although these attractive interactions, which were
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packing, also were shown by Rakotomanga et al. [44], we were
not able to detect formation of HePC/sterol-rich domains by
CTL quenching assay (Fig. 1A). Similarly, at temperatures
over 5 C cholestatrienol was not able to report the melting
of sterol-rich domains in bilayer system containing POPC in
contrast to bilayer system containing DPPC [23], even if signif-
icant condensing eﬀect of cholesterol on both DPPC and
POPC has been demonstrated in monolayers [45].
In our previous study we have shown that removal of three
methyl groups from the PSM phosphocholine headgroup dis-
abled the formation of sphingomyelin/sterol-rich domains de-
spite of preserved hydrogen bonding properties and acyl
chain saturation [46]. The observation that HePC and OMPC
were not able to form sterol-rich domains although both lipids
contain saturated acyl chain, point again to the importance of
headgroup size and properties for formation of ordered do-
mains. Both HePC and OMPC have a conical shape and can
therefore be expected to behave similarly as the more exten-
sively studied lysophosphatidylcholines. When dispersed in
water lysophosphatidylcholines form micelles, but equimolar
lysophosphatidylcholine:cholesterol mixtures form multilamel-
lar liposomes [47]. The destabilizing eﬀect of lysophospholipids
on phosphatidylcholine bilayers is counteracted by addition of
cholesterol and formation of lysophosphatidylcholine:choles-
terol 1:1 complexes [48]. Although similar complexes may form
between HePC or OMPC and cholesterol in a ﬂuid bilayer,
anti-tumor ether lipids and cholesterol apparently do not form
large ordered domains capable of shielding the ﬂuorescentCTL from quenching. Likewise, we have not been able to de-
tect a formation of ordered domains by 1-palmitoyl-2-OH-
phosphatidylcholine and cholesterol in POPC bilayers using
the CTL quenching assay (data not shown). We also cannot
exclude the possibility that alkyllysophospholipids and
alkylphosphocholines form ordered domains of such small size
that the CTL probe is not eﬀectively shielded from quenching
by 7SLPC in the ﬂuid phase. However, our results enable us to
conclude that the saturated anti-tumor ether lipids (OMPC
and HePC) do not form ordered domains of the same nature
as double chain DHPC and PSM.
The quenching assay showed clearly that anti-tumor ether
lipids aﬀected PSM/sterol-rich domains in complex lipid bilay-
ers which imply at least partial mutual miscibility. The DSC
data (Fig. 3) conﬁrmed good miscibility of ether lipids with
PSM although some phase separation was observed particu-
larly in cooling scans. Our ﬁnding that anti-tumor ether lipids
stabilize sphingomyelin/sterol-rich domains supports results
from several cell studies suggesting that alkyllysophospholi-
pids require the presence of membrane rafts for their cellular
activity. Edelfosine (OMPC) has been shown to be internalized
by raft dependent endocytosis to inhibit PC synthesis inside
the mouse T lymphoma cells [20,21] and to aﬀect the protein
composition of lipid rafts in yeast and human leukemic cells
[16,22]. Disruption of rafts by depletion of cholesterol or by
hydrolysis of sphingomyelin led to reduced cytotoxicity of
edelfosine [16,20,21]. In study by Gajate [16] binding of ﬂuo-
rescent cholera toxin B subunit to GM1 was used to look at
distribution of membrane rafts in Jurkat cells. It was shown
B. Heczkova´, J.P. Slotte / FEBS Letters 580 (2006) 2471–2476 2475that treatment of cells with edelfosine led to redistribution of
lipid rafts from highly dispersed to dense patches followed
by capping of Fas into rafts and cell death. Our results support
the idea of stabilization of lipid domains by edelfosine as a way
of activation of Fas and triggering apoptosis.
The antiproliferative eﬀect of alkyllysophospholipids has
been connected to perturbations in signal transduction path-
ways involved in growth regulation. These perturbations could
be caused by the eﬀects of ether lipids on lipid rafts since it is
known that rafts are involved in several signaling processes
[49]. It has been suggested that alkylphospholipids induce
internalization of EGF receptors in A431 carcinoma cells by
aﬀecting the lipid microenviroment of the receptor [50]. At
the same time assembly of the molecular machinery necessary
for EGF receptor internalization takes place within lipid raft
platforms [51].
To conclude, we were able to show that ether lipids consid-
erably stabilized PSM/sterol-rich domains against temperature
induced melting. This suggests that association of ether lipids
with lipid rafts in plasma membranes is possible and that lipid
raft properties are drastically changed in the presence of anti-
tumor ether lipids. Lipid rafts may therefore be considered a
new potential target in anticancer therapy.
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